424 related articles for article (PubMed ID: 29572615)
21. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.
Wang W; Kandimalla R; Huang H; Zhu L; Li Y; Gao F; Goel A; Wang X
Semin Cancer Biol; 2019 Apr; 55():37-52. PubMed ID: 29775690
[TBL] [Abstract][Full Text] [Related]
22. Chasing the personalized medicine dream through biomarker validation in colorectal cancer.
Patil H; Saxena SG; Barrow CJ; Kanwar JR; Kapat A; Kanwar RK
Drug Discov Today; 2017 Jan; 22(1):111-119. PubMed ID: 27693431
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.
De Mattia E; Cecchin E; Toffoli G
Drug Resist Updat; 2015 May; 20():39-70. PubMed ID: 26027741
[TBL] [Abstract][Full Text] [Related]
24. New trends in molecular and cellular biomarker discovery for colorectal cancer.
Aghagolzadeh P; Radpour R
World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
[TBL] [Abstract][Full Text] [Related]
25. Precision medicine for metastatic colorectal cancer: an evolving era.
Guler I; Askan G; Klostergaard J; Sahin IH
Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):919-931. PubMed ID: 31475851
[No Abstract] [Full Text] [Related]
26. Circulating tumor cells in colorectal cancer in the era of precision medicine.
Hu M; Wang Z; Wu Z; Ding P; Pei R; Wang Q; Xing C
J Mol Med (Berl); 2022 Feb; 100(2):197-213. PubMed ID: 34802071
[TBL] [Abstract][Full Text] [Related]
27. Clinical management of metastatic colorectal cancer in the era of precision medicine.
Ciardiello F; Ciardiello D; Martini G; Napolitano S; Tabernero J; Cervantes A
CA Cancer J Clin; 2022 Jul; 72(4):372-401. PubMed ID: 35472088
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.
Furtado LV; Samowitz WS
Virchows Arch; 2017 Aug; 471(2):235-242. PubMed ID: 28551725
[TBL] [Abstract][Full Text] [Related]
29. The Association Between Primary Source of Healthcare Coverage and Colorectal Cancer Screening Among US Veterans.
May FP; Yano EM; Provenzale D; Neil Steers W; Washington DL
Dig Dis Sci; 2017 Aug; 62(8):1923-1932. PubMed ID: 28528373
[TBL] [Abstract][Full Text] [Related]
30. Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches.
Atreya CE; Yaeger R; Chu E
Am Soc Clin Oncol Educ Book; 2017; 37():246-256. PubMed ID: 28561718
[TBL] [Abstract][Full Text] [Related]
31. Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies.
Akkad J; Bochum S; Martens UM
Langenbecks Arch Surg; 2015 Feb; 400(2):129-43. PubMed ID: 25701352
[TBL] [Abstract][Full Text] [Related]
32. Biomarker Identification through Proteomics in Colorectal Cancer.
Martín-García D; García-Aranda M; Redondo M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396959
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
[TBL] [Abstract][Full Text] [Related]
34. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
35. The emerging era of personalized medicine in advanced colorectal cancer.
Wu CWK; Reid M; Leedham S; Lui RN
J Gastroenterol Hepatol; 2022 Aug; 37(8):1411-1425. PubMed ID: 35815339
[TBL] [Abstract][Full Text] [Related]
36. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
Hall WA; Bergom C; Thompson RF; Baschnagel AM; Vijayakumar S; Willers H; Li XA; Schultz CJ; Wilson GD; West CML; Capala J; Coleman CN; Torres-Roca JF; Weidhaas J; Feng FY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):274-284. PubMed ID: 28964588
[TBL] [Abstract][Full Text] [Related]
37. Biological and clinical markers in colorectal cancer: state of the art.
Cappellani A; Di Vita M; Zanghi A; Veroux P; Cavallaro A; Lo Menzo E; Cacopardo B; Canzonieri V; Murabito P; Tirelli U; Berretta M
Front Biosci (Schol Ed); 2010 Jan; 2(2):422-31. PubMed ID: 20036958
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs for Diagnosis and Treatment of Colorectal Cancer.
Mei H; Wen Y
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):47-55. PubMed ID: 32819240
[TBL] [Abstract][Full Text] [Related]
39. Integrated approaches for precision oncology in colorectal cancer: The more you know, the better.
Andrei P; Battuello P; Grasso G; Rovera E; Tesio N; Bardelli A
Semin Cancer Biol; 2022 Sep; 84():199-213. PubMed ID: 33848627
[TBL] [Abstract][Full Text] [Related]
40. Personalized medicine: Stem cells in colorectal cancer treatment.
Patsalias A; Kozovska Z
Biomed Pharmacother; 2021 Sep; 141():111821. PubMed ID: 34144456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]